Top 12 Biotech Venture Capital Firm Managers by Managed AUM

SWFI deals

Rankings by Total Managed AUM

RankProfileManaged AUMTypeRegion
1.Redmile Group$11,582,222,474Biotech Venture Capital FirmNorth America
2.RTW Investments$8,730,907,156Biotech Venture Capital FirmNorth America
3.Vivo Capital, LLC$5,800,000,000Biotech Venture Capital FirmNorth America
4.Casdin Capital$5,202,118,702Biotech Venture Capital FirmNorth America
5.Avoro Capital$5,068,640,536Biotech Venture Capital FirmNorth America
6.Foresite Capital$3,490,000,000Biotech Venture Capital FirmNorth America
7.Decheng Capital$2,209,685,789Biotech Venture Capital FirmAsia
8.SV Health Investors$1,742,253,489Biotech Venture Capital FirmNorth America
9.Deep Track Capital$1,122,663,357Biotech Venture Capital FirmNorth America
10.LYFE Capital$1,100,000,000Biotech Venture Capital FirmAsia
11.Osage University PartnersBiotech Venture Capital FirmNorth America
12.Hadean VenturesBiotech Venture Capital FirmEurope
 $46,867,423,503  

If you are a journalist writing a story, an academic writing a research paper or a manager writing a report, we request that you reach out to us for permission to republish this data. Additionally, we may have updated information that is not yet reflected in this table.

If you would like to produce the full rankings page, please reach out to the Research Team.

View Other Managed AUM Rankings by Type